Sequencing of the human genome has led to the discovery that while less than two percent of the genome codes for proteins, most of it — perhaps greater than 90 percent — is primarily dedicated to making a wide variety of RNA molecules. These RNAs have been implicated in diverse biological activities and diseases, opening new approaches to personalized medical treatment.



The co-directors of the U-M Center for RNA Biomedicine, Mats Ljungman and Nils Walter, will outline the tools now available to study and manipulate RNA and how they have the potential to build a bridge from laboratory to clinic. They also will outline their vision for accelerating RNA research at UM through the recent funding obtained from Biosciences Initiative.

These talks are open to everyone and free, but please register.